BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23239555)

  • 1. Boron-based inhibitors of acyl protein thioesterases 1 and 2.
    Zimmermann TJ; Bürger M; Tashiro E; Kondoh Y; Martinez NE; Görmer K; Rosin-Steiner S; Shimizu T; Ozaki S; Mikoshiba K; Watanabe N; Hall D; Vetter IR; Osada H; Hedberg C; Waldmann H
    Chembiochem; 2013 Jan; 14(1):115-22. PubMed ID: 23239555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of highly potent inhibitors of the Ras-targeting human acyl protein thioesterases based on substrate similarity design.
    Hedberg C; Dekker FJ; Rusch M; Renner S; Wetzel S; Vartak N; Gerding-Reimers C; Bon RS; Bastiaens PI; Waldmann H
    Angew Chem Int Ed Engl; 2011 Oct; 50(42):9832-7. PubMed ID: 21905185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule inhibition of APT1 affects Ras localization and signaling.
    Dekker FJ; Rocks O; Vartak N; Menninger S; Hedberg C; Balamurugan R; Wetzel S; Renner S; Gerauer M; Schölermann B; Rusch M; Kramer JW; Rauh D; Coates GW; Brunsveld L; Bastiaens PI; Waldmann H
    Nat Chem Biol; 2010 Jun; 6(6):449-56. PubMed ID: 20418879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of acyl protein thioesterases 1 and 2 as the cellular targets of the Ras-signaling modulators palmostatin B and M.
    Rusch M; Zimmermann TJ; Bürger M; Dekker FJ; Görmer K; Triola G; Brockmeyer A; Janning P; Böttcher T; Sieber SA; Vetter IR; Hedberg C; Waldmann H
    Angew Chem Int Ed Engl; 2011 Oct; 50(42):9838-42. PubMed ID: 21905186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and biological evaluation of acyl protein thioesterase 1 (APT1) inhibitors.
    Deck P; Pendzialek D; Biel M; Wagner M; Popkirova B; Ludolph B; Kragol G; Kuhlmann J; Giannis A; Waldmann H
    Angew Chem Int Ed Engl; 2005 Aug; 44(31):4975-80. PubMed ID: 16003812
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and evaluation of acyl protein thioesterase 1 (APT1) inhibitors.
    Biel M; Deck P; Giannis A; Waldmann H
    Chemistry; 2006 May; 12(15):4121-43. PubMed ID: 16528788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Mechanism for Isoform-Selective Inhibition of Acyl Protein Thioesterases 1 and 2 (APT1 and APT2).
    Won SJ; Davda D; Labby KJ; Hwang SY; Pricer R; Majmudar JD; Armacost KA; Rodriguez LA; Rodriguez CL; Chong FS; Torossian KA; Palakurthi J; Hur ES; Meagher JL; Brooks CL; Stuckey JA; Martin BR
    ACS Chem Biol; 2016 Dec; 11(12):3374-3382. PubMed ID: 27748579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Ras palmitoylation/depalmitoylation cycle in cancer.
    Lin DTS; Davis NG; Conibear E
    Biochem Soc Trans; 2017 Aug; 45(4):913-921. PubMed ID: 28630138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling and inhibiting reversible palmitoylation.
    Hernandez JL; Majmudar JD; Martin BR
    Curr Opin Chem Biol; 2013 Feb; 17(1):20-6. PubMed ID: 23287289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic palmitoylation links cytosol-membrane shuttling of acyl-protein thioesterase-1 and acyl-protein thioesterase-2 with that of proto-oncogene H-ras product and growth-associated protein-43.
    Kong E; Peng S; Chandra G; Sarkar C; Zhang Z; Bagh MB; Mukherjee AB
    J Biol Chem; 2013 Mar; 288(13):9112-25. PubMed ID: 23396970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Solid-Phase Construction of Serine Hydrolase Probes Results in Selective Activity-Based Probes for Acyl Protein Thioesterases-1/2.
    Vanhoutte R; van de Plassche MAT; Verhelst SHL
    J Med Chem; 2020 Oct; 63(20):11845-11853. PubMed ID: 32990443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
    Lobell RB; Omer CA; Abrams MT; Bhimnathwala HG; Brucker MJ; Buser CA; Davide JP; deSolms SJ; Dinsmore CJ; Ellis-Hutchings MS; Kral AM; Liu D; Lumma WC; Machotka SV; Rands E; Williams TM; Graham SL; Hartman GD; Oliff AI; Heimbrook DC; Kohl NE
    Cancer Res; 2001 Dec; 61(24):8758-68. PubMed ID: 11751396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The autodepalmitoylating activity of APT maintains the spatial organization of palmitoylated membrane proteins.
    Vartak N; Papke B; Grecco HE; Rossmannek L; Waldmann H; Hedberg C; Bastiaens PI
    Biophys J; 2014 Jan; 106(1):93-105. PubMed ID: 24411241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
    Lingham RB; Silverman KC; Jayasuriya H; Kim BM; Amo SE; Wilson FR; Rew DJ; Schaber MD; Bergstrom JD; Koblan KS; Graham SL; Kohl NE; Gibbs JB; Singh SB
    J Med Chem; 1998 Nov; 41(23):4492-501. PubMed ID: 9804689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical biology of lipidated proteins.
    Triola G; Waldmann H; Hedberg C
    ACS Chem Biol; 2012 Jan; 7(1):87-99. PubMed ID: 22148864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatic protein depalmitoylation by acyl protein thioesterases.
    Lin DT; Conibear E
    Biochem Soc Trans; 2015 Apr; 43(2):193-8. PubMed ID: 25849916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Bromopalmitate reduces protein deacylation by inhibition of acyl-protein thioesterase enzymatic activities.
    Pedro MP; Vilcaes AA; Tomatis VM; Oliveira RG; Gomez GA; Daniotti JL
    PLoS One; 2013; 8(10):e75232. PubMed ID: 24098372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity.
    Kim JH; Resende R; Wennekes T; Chen HM; Bance N; Buchini S; Watts AG; Pilling P; Streltsov VA; Petric M; Liggins R; Barrett S; McKimm-Breschkin JL; Niikura M; Withers SG
    Science; 2013 Apr; 340(6128):71-5. PubMed ID: 23429702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligomycins as inhibitors of K-Ras plasma membrane localisation.
    Salim AA; Tan L; Huang XC; Cho KJ; Lacey E; Hancock JF; Capon RJ
    Org Biomol Chem; 2016 Jan; 14(2):711-715. PubMed ID: 26565618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAS: target for cancer therapy.
    Saxena N; Lahiri SS; Hambarde S; Tripathi RP
    Cancer Invest; 2008 Nov; 26(9):948-55. PubMed ID: 18798058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.